中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/12/09 | 3,040 | 3,115 | 3,035 | 3,095 | +50 | +1.6% | 2,375,700 |
| 2016/12/08 | 3,055 | 3,060 | 3,010 | 3,045 | -15 | -0.5% | 1,330,000 |
| 2016/12/07 | 3,095 | 3,100 | 3,060 | 3,060 | -30 | -1% | 914,400 |
| 2016/12/06 | 3,145 | 3,145 | 3,080 | 3,090 | +5 | +0.2% | 1,213,000 |
| 2016/12/05 | 3,140 | 3,160 | 3,075 | 3,085 | -70 | -2.2% | 1,402,200 |
| 2016/12/02 | 3,180 | 3,195 | 3,115 | 3,155 | -50 | -1.6% | 1,510,900 |
| 2016/12/01 | 3,220 | 3,255 | 3,195 | 3,205 | -10 | -0.3% | 1,437,200 |
| 2016/11/30 | 3,250 | 3,250 | 3,205 | 3,215 | -35 | -1.1% | 1,471,900 |
| 2016/11/29 | 3,220 | 3,270 | 3,220 | 3,250 | +15 | +0.5% | 936,400 |
| 2016/11/28 | 3,230 | 3,250 | 3,225 | 3,235 | -20 | -0.6% | 906,300 |
| 2016/11/25 | 3,235 | 3,260 | 3,230 | 3,255 | +30 | +0.9% | 1,024,700 |
| 2016/11/24 | 3,295 | 3,300 | 3,215 | 3,225 | -85 | -2.6% | 1,635,000 |
| 2016/11/22 | 3,300 | 3,315 | 3,285 | 3,310 | ±0 | ±0% | 1,198,700 |
| 2016/11/21 | 3,290 | 3,320 | 3,290 | 3,310 | +20 | +0.6% | 1,155,400 |
| 2016/11/18 | 3,325 | 3,345 | 3,270 | 3,290 | -35 | -1.1% | 1,455,800 |
| 2016/11/17 | 3,260 | 3,330 | 3,260 | 3,325 | -5 | -0.2% | 969,800 |
| 2016/11/16 | 3,300 | 3,340 | 3,285 | 3,330 | +55 | +1.7% | 1,215,600 |
| 2016/11/15 | 3,310 | 3,325 | 3,265 | 3,275 | -20 | -0.6% | 1,214,900 |
| 2016/11/14 | 3,325 | 3,350 | 3,280 | 3,295 | ±0 | ±0% | 1,213,900 |
| 2016/11/11 | 3,380 | 3,385 | 3,290 | 3,295 | -60 | -1.8% | 2,531,200 |
| 2016/11/10 | 3,325 | 3,370 | 3,285 | 3,355 | +240 | +7.7% | 1,952,700 |
| 2016/11/09 | 3,290 | 3,335 | 3,110 | 3,115 | -145 | -4.4% | 2,433,400 |
| 2016/11/08 | 3,335 | 3,335 | 3,240 | 3,260 | -75 | -2.2% | 1,016,400 |
| 2016/11/07 | 3,325 | 3,345 | 3,300 | 3,335 | +60 | +1.8% | 1,344,600 |
| 2016/11/04 | 3,200 | 3,290 | 3,150 | 3,275 | -140 | -4.1% | 2,733,400 |
| 2016/11/02 | 3,480 | 3,480 | 3,375 | 3,415 | -65 | -1.9% | 876,600 |
| 2016/11/01 | 3,555 | 3,565 | 3,475 | 3,480 | -100 | -2.8% | 1,013,300 |
| 2016/10/31 | 3,570 | 3,605 | 3,550 | 3,580 | -15 | -0.4% | 975,900 |
| 2016/10/28 | 3,550 | 3,610 | 3,535 | 3,595 | +115 | +3.3% | 1,706,200 |
| 2016/10/27 | 3,490 | 3,500 | 3,445 | 3,480 | -10 | -0.3% | 1,135,600 |
| 2016/10/26 | 3,430 | 3,590 | 3,390 | 3,490 | -80 | -2.2% | 2,512,200 |
| 2016/10/25 | 3,590 | 3,595 | 3,540 | 3,570 | ±0 | ±0% | 615,900 |
| 2016/10/24 | 3,575 | 3,600 | 3,555 | 3,570 | +15 | +0.4% | 694,600 |
| 2016/10/21 | 3,625 | 3,625 | 3,550 | 3,555 | -35 | -1% | 934,500 |
| 2016/10/20 | 3,570 | 3,600 | 3,550 | 3,590 | +15 | +0.4% | 1,000,800 |
| 2016/10/19 | 3,575 | 3,615 | 3,560 | 3,575 | -10 | -0.3% | 825,500 |
| 2016/10/18 | 3,535 | 3,615 | 3,535 | 3,585 | +30 | +0.8% | 725,700 |
| 2016/10/17 | 3,535 | 3,565 | 3,505 | 3,555 | +5 | +0.1% | 1,042,100 |
| 2016/10/14 | 3,575 | 3,610 | 3,545 | 3,550 | -95 | -2.6% | 1,524,100 |
| 2016/10/13 | 3,645 | 3,675 | 3,630 | 3,645 | -15 | -0.4% | 725,100 |
| 2016/10/12 | 3,670 | 3,695 | 3,650 | 3,660 | -65 | -1.7% | 777,800 |
| 2016/10/11 | 3,690 | 3,725 | 3,675 | 3,725 | +75 | +2.1% | 826,300 |
| 2016/10/07 | 3,675 | 3,685 | 3,635 | 3,650 | -25 | -0.7% | 371,100 |
| 2016/10/06 | 3,700 | 3,700 | 3,635 | 3,675 | -5 | -0.1% | 620,500 |
| 2016/10/05 | 3,685 | 3,700 | 3,645 | 3,680 | +20 | +0.5% | 620,000 |
| 2016/10/04 | 3,630 | 3,660 | 3,600 | 3,660 | ±0 | ±0% | 971,500 |
| 2016/10/03 | 3,665 | 3,680 | 3,640 | 3,660 | +25 | +0.7% | 439,200 |
| 2016/09/30 | 3,640 | 3,665 | 3,595 | 3,635 | -30 | -0.8% | 877,900 |
| 2016/09/29 | 3,660 | 3,690 | 3,635 | 3,665 | +20 | +0.5% | 813,600 |
| 2016/09/28 | 3,630 | 3,655 | 3,610 | 3,645 | -35 | -1% | 773,700 |
2051～
2100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
